newsfilter
← Latest News
PR Newswire·

Seqirus Awarded U.S. Government Contract to Develop Two Pandemic Influenza Vaccines

SUMMIT, N.J., Oct. 4, 2021 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced that the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the